Singapore Markets closed

Straits Times Index
3,139.76
-43.52(-1.37%)
S&P 500
3,916.64
-43.64(-1.10%)
Dow
31,861.98
-384.62(-1.19%)
Nasdaq
11,630.51
-86.79(-0.74%)
BTC-USD
28,288.64
+1,204.11(+4.45%)
CMC Crypto 200
615.67
+43.66(+7.63%)

Galapagos NV (GLPG.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR

Add to watchlist

35.75

-0.92

(-2.51%)

As of 10:55AM CET. Market open.

All

Zacks
3 Beaten-Down Drug Stocks Poised for a Turnaround in 2023
Here we present three drug and biotech stocks, VIR, GLPG and PCRX, which took a beating in 2022 but have upside potential for 2023, despite an uncertain macro environment.
Zacks
Does Galapagos NV (GLPG) Have the Potential to Rally 34% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.4% in Galapagos NV (GLPG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
Down 5.9% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround
Galapagos NV (GLPG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.